NCT01460849View on ClinicalTrials.gov

Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Cystic Fibrosis
Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY